Bispecific antibody for specifically neutralizing TGF-beta signal of helper T cell, pharmaceutical composition and application thereof
The invention relates to the technical field of biology, and particularly relates to a bispecific antibody for specifically neutralizing a TGF-beta signal of a helper T cell. The bispecific antibody at least comprises a first protein chain and a second protein chain, wherein the first protein chain...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to the technical field of biology, and particularly relates to a bispecific antibody for specifically neutralizing a TGF-beta signal of a helper T cell. The bispecific antibody at least comprises a first protein chain and a second protein chain, wherein the first protein chain comprises a part or all of the structure of a first protein functional region, and/or a part or allof the structure of a second protein functional region; the first protein functional region targets CD4; the second protein functional region targets TGF beta 1; and the optimized anti-CD4/anti-TGF-beta 1 bifunctional antibody can efficiently neutralize the TGF-beta signal of the helper T cell with high affinity, affinity and specificity. Specifically, the optimized anti-CD4/anti-TGF-beta 1 bifunctional antibody, represented in the form of IgG-(L)-ScFv, can inhibit the TGF-beta signal pathway of the helper T cell with higher neutralizing efficacy, and can achieve the same cancer inhibiting effect with lower drug conce |
---|---|
AbstractList | The invention relates to the technical field of biology, and particularly relates to a bispecific antibody for specifically neutralizing a TGF-beta signal of a helper T cell. The bispecific antibody at least comprises a first protein chain and a second protein chain, wherein the first protein chain comprises a part or all of the structure of a first protein functional region, and/or a part or allof the structure of a second protein functional region; the first protein functional region targets CD4; the second protein functional region targets TGF beta 1; and the optimized anti-CD4/anti-TGF-beta 1 bifunctional antibody can efficiently neutralize the TGF-beta signal of the helper T cell with high affinity, affinity and specificity. Specifically, the optimized anti-CD4/anti-TGF-beta 1 bifunctional antibody, represented in the form of IgG-(L)-ScFv, can inhibit the TGF-beta signal pathway of the helper T cell with higher neutralizing efficacy, and can achieve the same cancer inhibiting effect with lower drug conce |
Author | CHENG HANBING |
Author_xml | – fullname: CHENG HANBING |
BookMark | eNqNTbkOwjAM7QAD1z-YHSTKMTBCxTExdUcmdaglE0dJGMoH8N0UBDvT07v7Wcepo1723HL0ZNiyAXSJL1o1YDXAT0WRBhzdU0DhB7srlIf99EIJIfLVoYBaqEk8BSjBkMgEfI3hhqYtvftg9OY1cmJ17UcF6L20xoenmgKpHWZdixJp9MVBNt7vyuI4Ja9nir4dc5TOxSnP56vZbLnON4t_Mi_PSk1n |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 一种特异性中和辅助性T细胞TGF-β信号的双特异性抗体、其药物组合及其用途 |
ExternalDocumentID | CN112500491A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN112500491A3 |
IEDL.DBID | EVB |
IngestDate | Fri Oct 11 05:28:27 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN112500491A3 |
Notes | Application Number: CN202011502521 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210316&DB=EPODOC&CC=CN&NR=112500491A |
ParticipantIDs | epo_espacenet_CN112500491A |
PublicationCentury | 2000 |
PublicationDate | 20210316 |
PublicationDateYYYYMMDD | 2021-03-16 |
PublicationDate_xml | – month: 03 year: 2021 text: 20210316 day: 16 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | SHENZHEN MAIJIARUI BIOTECHNOLOGY CO., LTD |
RelatedCompanies_xml | – name: SHENZHEN MAIJIARUI BIOTECHNOLOGY CO., LTD |
Score | 3.4502866 |
Snippet | The invention relates to the technical field of biology, and particularly relates to a bispecific antibody for specifically neutralizing a TGF-beta signal of a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | Bispecific antibody for specifically neutralizing TGF-beta signal of helper T cell, pharmaceutical composition and application thereof |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210316&DB=EPODOC&locale=&CC=CN&NR=112500491A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEF5qFfWmVdH6YATJyWBiNklzCGKTxiKYFonSW8ljl1ZCEmyKtD_A3-1OSG0velt2yYaZZTJfZr6ZJeQm0UwahhqXLTPRZaqZoRwlmiHzyOpYTKOGeA7ZFr7Rf6PPI33UIB-rWpiqT-hX1RxRWFQs7L2svtfFOojlVtzK2V00FVP5gxfYrlT_Hd_jpQWG5Hbt3nDgDhzJcWzHl_xXW8AKHdGw-rhFthFGY5_93nsXq1KKTZfiHZCdodgtKw9JYzlpkT1ndfNai-y-1AlvMaxtb3ZEvrtTLItEag8IdUyjPFmAgJywmg3TdAEZm1exi6VwSRA8eXIk5ABkaYQp5BwmLC3YJwSAEftbKCabIW1AgnnN4hLvSGAjvQ2IFFnOj8m11wucviwEGv9qb-z4a9m1E9LM8oydEohVypkShrFhUsp5x1J4rOiJ0qGIcFTzjLT_3qf93-I52ceTQKKWalyQZvk5Z5fCc5fRVaXyHyKjoKA |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rRqtrzUxnCSCLFAOxFgoVm1pY9D01vDYTWsIkJbGtD_A3-0uobYXvZElu2RmM8y3M9_MAtxEio59X6GioUeqiBXdF4NI0UQaGE2DKFhj8zjbwtU67_hlqA4r8LmqhSn6hH4VzRGZRYXM3vPif52tg1h2wa2c3QUTNpQ-OJ5pC-Xp-J5fWqAJdstsD_p23xIsy7RcwX0zGaxQORqWH7dgW2dHQt5nv_3R4lUp2aZLcfZhZ8BWS_IDqCzHdahZq5vX6rDbKxPe7LG0vdkhfLcmvCySU3sQU8ckSKMFYpATrUb9OF6ghMyL2MWSuSTkPTliwORAnKXhxyilaEzijEyRh3jE_hZl482QNuIE85LFxb4RoY30NuJIkaT0CK6dtmd1RCbQ6Fd7I8tdy64cQzVJE3ICKJQxJZLvh5qOMaVNQ6KhpEZSE3OEI-un0Ph7ncZ_L6-g1vF63VH32X09gz2-K5y0JWvnUM2nc3LBvHgeXBbq_wHM-qOL |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Bispecific+antibody+for+specifically+neutralizing+TGF-beta+signal+of+helper+T+cell%2C+pharmaceutical+composition+and+application+thereof&rft.inventor=CHENG+HANBING&rft.date=2021-03-16&rft.externalDBID=A&rft.externalDocID=CN112500491A |